The ApoC2 mimetic peptide D6PV enhances remyelination by stimulating oxidative phosphorylation in oligodendrocytes
Moonen, B.; Bolkaerts, L.; Poelmans, K.; Wouters, F.; Kuipers, K.; Guns, J.; Verberk, S. G. S.; Wolfs, E.; Doering, Y.; Jansen, Y.; Vanmierlo, T.; Dierckx, T.; Gibson, E.; Wolska, A.; Reimund, M.; Remaley, A. T.; Loix, M.; Hendriks, J. J. A.; Bogie, J. F. J.; Vanherle, S.
Show abstract
Failure of remyelination drives neurodegeneration in demyelinating disorders such as multiple sclerosis (MS), with disrupted lipid handling and metabolic stress in oligodendrocyte precursor cells (OPCs) posing major barriers to repair. Here, we identify the dual ApoC-II mimetic-ApoC-III antagonist peptide D6PV as a metabolic modulator that directly enhances OPC differentiation and myelin repair. Across ex vivo and in vivo models of chemically induced demyelination, D6PV promotes oligodendrocyte maturation and restores myelin integrity independently of lipoprotein hydrolysis or modulation of lipid droplet-containing phagocytes. Guided by transcriptomics analyses, we find that D6PV stimulates mitochondrial oxidative phosphorylation and fatty acid {beta}-oxidation, while suppressing inflammatory transcriptional programs, thereby driving OPCs toward a myelinating phenotype. Notably, D6PV does not alter peripheral immune composition or autoimmune-driven pathology in the experimental autoimmune encephalomyelitis model, indicating a central nervous system (CNS) cell-autonomous effect. These findings reveal a metabolism-linked pathway for remyelination and position D6PV as a promising therapeutic strategy to enhance CNS repair in demyelinating diseases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas/Casp8/Bid-axis 97%
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases 96%
- Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia 96%
Similar papers in this journal
- A unique cerebellar pattern of microglia activation in a mousemodel of encephalopathy of prematurity 96%
- The Fragile X Messenger Ribonucleoprotein 1 regulates the morphology and maturation of human and rat oligodendrocytes 95%
- Generation of an inducible destabilized-domain Cre mouse line to target disease associated microglia 95%
Similar papers in this journal
- Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia 96%
- Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone 96%
- Role of PARP1 in oligodendrocyte differentiation during developmental myelination and remyelination after myelin damage 96%
Similar papers in this journal
Similar papers in this journal
- Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity 94%
- Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy 94%
- The effects of P2Y12 loss on microglial gene expression, dynamics, and injury response in the cerebellum and cerebral cortex. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.